kwic
data
data
right
off
ON
309
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for data out of >500 occurrences
617251 occurrences (No.12 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to data]
617251 occurrences (No.12 in the rank) during 5 years in the PubMed. [cache]
| 309) Our data support the use of venous ECs for TE because of their beneficial antithrombogenic profile. |
| PMID:23166106 DOI:10.1002/term.1642 |
| 2015 Journal of tissue engineering and regenerative medicine |
| * Endothelial cells (ECs) for vascular tissue engineering: venous ECs are less thrombogenic than arterial ECs. |
| - Primary endothelial cells (ECs) are the preferred cellular source for luminal seeding of tissue-engineered (TE) vascular grafts. Research into the potential of ECs for vascular TE has focused particularly on venous rather than arterial ECs. In this study we evaluated the functional characteristics of arterial and venous ECs, relevant for vascular TE. Porcine ECs were isolated from femoral artery (PFAECs) and vein (PFVECs). The proliferation rate was comparable for both EC sources, whereas migration, determined through a wound-healing assay, was less profound for PFVECs. EC adhesion was lower for PFVECs on collagen I, measured after 10 min of arterial shear stress. Gene expression was analysed by qRT-PCR for ECs cultured under static conditions and after exposure to arterial shear stress and revealed differences in gene expression, with lower expression of EphrinB2 and VCAM-1 and higher levels of vWF and COUP-TFII in PFVECs than in PFAECs. PFVECs exhibited diminished platelet adhesion under flow and cell-based thrombin generation was delayed for PFVECs, indicating diminished tissue factor (TF) activity. After stimulation, prostacyclin secretion, but not nitric oxide (NO), was lower in PFVECs. Our data support the use of venous ECs for TE because of their beneficial antithrombogenic profile. |
[
right
kwic]
(1)70  from |
(14)7 revealed |
(27)3 analyses |
(40)2 at |
| (2)55 were |
(15)7 support |
(28)3 can |
(41)2 by |
| (3)32 *null* | (16)7 was |
(29)3 concerning |
(42)2 clearly |
| (4)26 on |
(17)6 analysis |
(30)3 in |
(43)2 clustering |
| (5)19 and |
(18)6 obtained |
(31)3 indicated |
(44)2 have |
| (6)18 for |
(19)5 collection |
(32)3 may |
(45)2 here |
| (7)17 suggest |
(20)5 sets |
(33)3 the |
(46)2 highlight |
| (8)13 are |
(21)5 showed |
(34)3 which |
(47)2 mining |
| (9)11 set |
(22)5 we |
(35)3 with |
(48)2 show |
| (10)11 to |
(23)4 demonstrate |
(36)3 would |
(49)2 shows |
| (11)9 of |
(24)4 is |
(37)2 about |
|
| (12)7 collected |
(25)4 provide |
(38)2 also |
|
| (13)7 indicate |
(26)4 regarding |
(39)2 as |
add keyword
--- WordNet output for data ---